卵巢癌是妇科三大恶性肿瘤之一,目前其治疗方式以手术为主,化学治疗为辅,但因发现时多已为晚期,手术治疗效果差或丧失了手术机会,加之化疗耐药现象严重,而且,随着疗程的延长,最终至少有80%的化疗患者出现继发性耐药。耐药的产生直接影响化疗效果和患者的生存率,因此,卵巢癌病死 Ovarian cancer is one of the three major malignant tumors of gynecology. At present, its treatment is mainly based on surgery and chemical treatment is supplemented. However, it is found to be late due to poor surgical treatment or the chance of surgery is lost. In addition, chemotherapy resistance is serious , And eventually, at least 80% of chemotherapy patients eventually develop secondary resistance as the course of treatment increases. The emergence of drug resistance directly affects the efficacy of chemotherapy and the survival rate of patients, therefore, ovarian cancer died